OTCMKTS:BNXTF BioNxt Solutions (BNXTF) Stock Price, News & Analysis $0.40 +0.05 (+14.61%) As of 10:56 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesShort InterestBuy This Stock About BioNxt Solutions Stock (OTCMKTS:BNXTF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BioNxt Solutions alerts:Sign Up Key Stats Today's Range$0.40▼$0.4050-Day Range$0.26▼$0.4152-Week Range$0.11▼$0.43Volume5,011 shsAverage Volume8,157 shsMarket Capitalization$46.30 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview BioNxt Solutions Inc. engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains. In addition, the company offers psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. Further, it provides analytical testing and consulting services. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. The company was incorporated in 2017 and is headquartered in Vancouver, Canada. Read More Receive BNXTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioNxt Solutions and its competitors with MarketBeat's FREE daily newsletter. Email Address BNXTF Stock News HeadlinesBioNxt Solutions Inc.: BioNxt Solutions Announces Revocation of Management Cease Trade OrderJune 29 at 2:51 PM | finanznachrichten.deBioNxt Solutions Announces Revocation of Management Cease Trade Order - MorningstarJune 29 at 9:51 AM | morningstar.comMThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.July 2 at 2:00 AM | Paradigm Press (Ad)BioNxt Solutions Launches Feasibility Study for Semaglutide Oral Thin FilmJune 25, 2025 | tipranks.comBNXTF BioNxt Solutions Inc.June 22, 2025 | seekingalpha.comBioNxt Solutions Secures Key European Patent for Sublingual Drug DeliveryMay 26, 2025 | tipranks.comBioNxt Solutions Inc.: Bionxt Solutions Provides Bi-Weekly MCTO Status ReportMay 16, 2025 | finanznachrichten.deBioNxt Solutions Provides Update on Management Cease Trade OrderMay 15, 2025 | tipranks.comSee More Headlines BNXTF Stock Analysis - Frequently Asked Questions How have BNXTF shares performed this year? BioNxt Solutions' stock was trading at $0.2519 at the start of the year. Since then, BNXTF stock has increased by 58.8% and is now trading at $0.40. View the best growth stocks for 2025 here. How were BioNxt Solutions' earnings last quarter? BioNxt Solutions Inc. (OTCMKTS:BNXTF) released its quarterly earnings results on Thursday, June, 26th. The company reported ($0.01) EPS for the quarter. How do I buy shares of BioNxt Solutions? Shares of BNXTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings6/26/2025Today7/02/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - DRUGS Sub-IndustryN/A Current SymbolOTCMKTS:BNXTF CIKN/A Webwww.xphyto.com Phone780-818-6422FaxN/AEmployees20Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.80 million Net Margins-19,165.00% Pretax MarginN/A Return on EquityN/A Return on Assets-616.01% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$20 thousand Price / Sales2,315.24 Cash FlowN/A Price / Cash FlowN/A Book Value($0.04) per share Price / Book-10.00Miscellaneous Outstanding Shares115,762,000Free FloatN/AMarket Cap$46.30 million OptionableNot Optionable Beta0.81 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free Report This page (OTCMKTS:BNXTF) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersSomething very strange is happening...What a "Mar-a-Lago Accord" could mean for the U.S. dollar While protests dominate the news... hardly anyone...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNxt Solutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNxt Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.